| Neoplasm by Site investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 398show all (up to 200) |
|---|
| → investigated in trials for | Cyclophosphamidesmall molecule 535 trials (120 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 535 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 379 trials (70 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 379 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 304 trials (36 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 304 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal antibody 251 trials (58 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 251 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 230 trials (29 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 230 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 207 trials (29 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 207 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 202 trials (77 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 202 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 191 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 191 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 186 trials (88 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 186 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 184 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 184 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 180 trials (45 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 180 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 163 trials (65 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 163 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 162 trials (38 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 162 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall molecule 162 trials (42 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 162 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 161 trials (42 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 161 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 159 trials (36 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 159 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 154 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 154 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 135 trials (61 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 135 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 131 trials (36 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 131 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 107 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 107 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 100 trials (26 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 100 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 100 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 100 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 99 trials (59 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 99 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 98 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 98 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 98 trials (33 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 98 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daunorubicinsmall molecule 95 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 95 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 90 trials (26 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 90 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 84 trials (50 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 84 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 84 trials (20 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 84 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 83 trials (21 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 83 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 80 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 80 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 80 trials (47 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 80 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 78 trials (18 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 78 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 74 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 74 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 64 trials (32 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 64 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 61 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 61 trials (18 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 61 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 59 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 58 trials (29 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 56 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 56 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 53 trials (14 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 53 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 52 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 51 trials (12 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 51 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 50 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 49 trials (27 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 49 trials (13 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 48 trials (33 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 48 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 48 trials (16 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 48 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 47 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 47 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 46 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 46 trials (12 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 44 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thioguaninesmall molecule 44 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 43 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 43 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 43 trials (28 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 42 trials (19 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 38 trials (16 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 38 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 37 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 36 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 34 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitomycinsmall molecule 34 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 33 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 33 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 33 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 32 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Toripalimabmonoclonal antibody 32 trials (10 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemtuzumab Ozogamicinadc 31 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 30 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 29 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 28 trials (14 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nilotinibsmall molecule 26 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 26 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 25 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 25 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 23 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 23 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 23 trials (17 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 22 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enfortumab Vedotinadc 22 trials (17 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 21 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 21 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pazopanibsmall molecule 20 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inotuzumab Ozogamicinadc 19 trials (14 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 19 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 19 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 18 trials (15 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panitumumabmonoclonal antibody 18 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 18 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 16 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 16 trials (12 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 16 trials (13 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 16 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 15 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 15 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 15 trials (11 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 15 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 15 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 15 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 14 trials (9 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 14 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX Regimen 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxyureasmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 13 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ripretinibsmall molecule 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 13 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 12 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 12 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 12 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Quizartinibsmall molecule 11 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 11 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cediranibsmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 10 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tagraxofuspother 10 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adebrelimabmonoclonal antibody 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adjuvant Chemotherapy 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFIRI Regimen 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lapatinibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Volasertibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Calaspargase Pegolother 8 trials (8 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Loncastuximab Tesirineadc 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinfluninesmall molecule 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avapritinibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bosutinibsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 7 trials (6 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dovitinibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | FOLFOX-4 Regimen 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fruquintinibsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Midostaurinsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitotanesmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Revumenibsmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sacituzumab Govitecanadc 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tegafursmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amsacrinesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlorambucilsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dactinomycinother 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lisocabtagene Maraleucelgene therapy 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lomustinesmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Odronextamabmonoclonal antibody 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal antibody 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bacillus Calmette-Guerin BCG 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | CAPOX Regimen 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Eribulinsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ganetespibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gilteritinibsmall molecule 5 trials (3 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumab/Nivolumab Regimen 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Levoleucovorinsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Niraparibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Omacetaxine Mepesuccinatesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pacritinibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pexidartinibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ribociclibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selpercatinibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tucatinibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Neoplasm by Site | 5 | Observed | clinicaltrials | graph → |